Skip to main content

Want a detailed portfolio tracker?

Durect (DRRX) Total Assets (2010 - 2025)

Durect (DRRX) total assets from Dec 31, 2010 to Jun 30, 2025. The current Durect (DRRX) total assets is $12M. You can adjust inflation or export chart.

Total Assets

Total Assets

Durect (DRRX) Total Assets CAGR table

PeriodCAGR
1 Year TTM-58.27%
3 Years TTM-41.19%
5 Years TTM-26.42%
10 Years TTM-10.13%
All Time TTM-5.87%

Annual Total Assets change of Durect (DRRX)

YearTotal AssetsChange
2024$18M
-59.39%
2023$45M
-24.81%
2022$60M
-34.67%
2021$92M
+21.62%
2020$76M
-12.07%
2019$86M
+72.04%
2018$50M
-5.86%
2017$53M
+31.10%
2016$41M
-13.38%
2015$47M
-6.61%
2014$50M
+22.68%
2013$41M
-11.14%
2012$46M
-6.63%
2011$49M
-27.18%
2010$68M
N/A

Comparison Durect (DRRX) total assets with competitors

Durect (DRRX) total assets is $12.48M.

TickerNameTotal AssetsUpside
RDYDr. Reddy`s Laboratories Ltd$567.88B+4550192.53%
UPCUniverse Pharmaceuticals Inc$69.30B+555216.03%
TEVATeva- Pharmaceutical Industries Ltd$40.04B+320733.33%
VTRSViatris Inc$36.83B+295049.04%
HLNHaleon plc$32.57B+260898.77%
BHCBausch Health Companies Inc$24.50B+196198.08%
ZTSZoetis Inc - Class A$15.15B+121326.28%
ELANElanco Animal Health Inc$13.22B+105845.51%
PRGOPerrigo Company plc$7.98B+63868.75%
UTHRUnited Therapeutics Corp$6.71B+53699.68%
NBIXNeurocrine Biosciences Inc$4.91B+39212.50%
ALKSAlkermes plc$4.26B+34019.20%
AMRXAmneal Pharmaceuticals Inc - Class A$3.54B+28267.13%
PBHPrestige Consumer Healthcare Inc$3.49B+27899.30%
LNTHLantheus Holdings Inc$2.35B+18702.78%
HIMSHims & Hers Health Inc - Class A$2.27B+18065.41%
TLRYTilray Brands Inc$2.07B+16524.38%
HCMHUTCHMED (China) Ltd$1.78B+14130.29%
COLLCollegium Pharmaceutical Inc$1.65B+13136.82%
AMPHAmphastar Pharmaceuticals Inc$1.65B+13106.43%
EVOEvotec SE$1.64B+13053.22%
SUPNSupernus Pharmaceuticals Inc$1.50B+11925.04%
PAHCPhibro Animal Health Corp - Class A$1.45B+11479.47%
ANIPANI Pharmaceuticals Inc$1.42B+11293.99%
ALVOAlvotech$1.42B+11287.56%
EBSEmergent Biosolutions Inc$1.32B+10480.13%
PCRXPacira BioSciences Inc$1.21B+9583.77%
INDVIndivior Plc$1.20B+9491.35%
CRONCronos Group Inc$1.17B+9291.90%
CGCCanopy Growth Corporation$1.11B+8763.72%
DVAXDynavax Technologies Corp$946.51M+7484.18%
KNSAKiniksa Pharmaceuticals International plc. - Class A$825.28M+6512.82%
ACBAurora Cannabis Inc$775.29M+6112.28%
INCRINC Research Holdings Inc$690.55M+5433.27%
OGIOrganiGram Holdings Inc$522.66M+4087.97%
ORGOOrganogenesis Holdings Inc - Class A$519.99M+4066.60%
BCRXBiocryst Pharmaceuticals Inc$465.05M+3626.38%
ESPREsperion Therapeutics Inc$462.53M+3606.16%
ZYBTZhengye Biotechnology Holding Ltd$436.47M+3397.37%
IRWDIronwood Pharmaceuticals Inc - Class A$434.57M+3382.10%
DCPHDeciphera Pharmaceuticals Inc$420.93M+3272.82%
HROWHarrow Inc$419.54M+3261.72%
LQDALiquidia Corp$401.53M+3117.41%
BIOABioAge Labs Inc$397.65M+3086.33%
XERSXeris Biopharma Holdings Inc$392.01M+3041.13%
KMDAKamada Ltd$383.02M+2969.08%
AKBAAkebia Therapeutics Inc$362.52M+2804.81%
AMLXAmylyx Pharmaceuticals Inc$293.60M+2252.59%
LFCRLifecore Biomedical Inc$225.50M+1706.88%
EOLSEvolus Inc$220.65M+1668.00%
SIGASIGA Technologies Inc$219.39M+1657.92%
ASRTAssertio Holdings Inc$211.30M+1593.10%
AVDLAvadel Pharmaceuticals plc$199.45M+1498.14%
ANIKAnika Therapeutics Inc$179.39M+1337.40%
AQSTAquestive Therapeutics Inc$141.13M+1030.81%
AYTUAytu BioPharma Inc$111.69M+794.94%
CTORCitius Oncology Inc$100.70M+706.88%
TKNOAlpha Teknova Inc$98.66M+690.52%
ETONEton Pharmaceuticals Inc$97.71M+682.93%
DERMJourney Medical Corp$91.53M+633.45%
IXHLIncannex Healthcare Ltd$80.28M+543.29%
SCYXScynexis Inc$77.63M+522.00%
CPIXCumberland Pharmaceuticals Inc$71.00M+468.87%
RMTIRockwell Medical Inc$57.42M+360.12%
BGMQilian International Holding Group Ltd - Class A$53.00M+324.71%
CPHIChina Pharma Holdings Inc$45.14M+261.73%
TXMDTherapeuticsMD Inc$37.58M+201.13%
BTAIBioXcel Therapeutics Inc$34.02M+172.64%
CRDLCardiol Therapeutics Inc - Class A$31.49M+152.31%
TLPHTalphera Inc$30.16M+141.63%
SBFMSunshine Biopharma Inc$27.93M+123.80%
BFRIBiofrontera Inc$24.79M+98.61%
IMCCIM Cannabis Corp$23.68M+89.78%
SXTCChina SXT Pharmaceuticals Inc$21.66M+73.59%
GELSGelteq Ltd$21.48M+72.08%
EVOKEvoke Pharma Inc$15.65M+25.40%
SNOASonoma Pharmaceuticals Inc$13.62M+9.16%
YCBDcbdMD Inc$12.25M-1.82%
PRFXPRF Technologies Ltd$12.00M-3.86%
SHPHShuttle Pharmaceuticals Holdings Inc$11.81M-5.37%
APUSApimeds Pharmaceuticals US Inc$9.25M-25.88%
INMInMed Pharmaceuticals Inc$9.13M-26.81%
RGCRegencell Bioscience Holdings Ltd$5.76M-53.88%
CABRCaring Brands Inc$2.17M-82.60%